COPPINI, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.712
EU - Europa 5.610
AS - Asia 1.085
AF - Africa 23
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 12.434
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.704
PL - Polonia 2.130
RU - Federazione Russa 1.456
IT - Italia 830
IE - Irlanda 413
SG - Singapore 350
SE - Svezia 299
CN - Cina 253
HK - Hong Kong 220
JO - Giordania 101
CH - Svizzera 88
IN - India 74
GB - Regno Unito 70
VN - Vietnam 67
FI - Finlandia 59
UA - Ucraina 54
DE - Germania 48
FR - Francia 47
BE - Belgio 35
ES - Italia 28
CI - Costa d'Avorio 19
GR - Grecia 16
NL - Olanda 13
CA - Canada 8
KR - Corea 8
RO - Romania 7
AT - Austria 3
JP - Giappone 3
NO - Norvegia 3
PH - Filippine 3
PT - Portogallo 3
BR - Brasile 2
DK - Danimarca 2
AU - Australia 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
HU - Ungheria 1
IR - Iran 1
LU - Lussemburgo 1
MK - Macedonia 1
MU - Mauritius 1
PK - Pakistan 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TR - Turchia 1
TZ - Tanzania 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 12.434
Salva come PNG Salva come JPEG
Città #
Warsaw 2.126
Santa Clara 994
Fairfield 745
Dublin 402
Chandler 375
Ashburn 346
Woodbridge 344
Seattle 320
Cambridge 297
Singapore 286
Florence 262
Houston 257
Wilmington 241
Ann Arbor 217
Hong Kong 144
Lawrence 128
Altamura 124
Princeton 99
Beijing 94
Bern 85
Mumbai 64
Buffalo 61
Dong Ket 57
Medford 56
San Diego 56
Shanghai 54
Boston 53
Moscow 46
New York 45
Boardman 42
Falls Church 35
Brussels 33
Rome 31
Barcelona 27
Kent 25
Munich 24
Norwalk 23
Helsinki 20
Abidjan 19
Milan 19
London 18
Andover 17
Dearborn 17
Redwood City 17
Scandicci 17
Phoenix 14
Hillsboro 12
Yubileyny 11
Guangzhou 10
Poggio A Caiano 10
Los Angeles 9
Redmond 9
Nanjing 8
Siena 7
Bologna 6
Fontebuona 6
Pistoia 6
Prato 6
Santa Maria A Monte 6
Toronto 6
Washington 6
Athens 5
Castelliri 5
Dallas 5
Livorno 5
Salerno 5
Saronno 5
Sesto Fiorentino 5
Tianjin 5
Amsterdam 4
Bolzano 4
Cagliari 4
Cleveland 4
Jacksonville 4
Las Vegas 4
Seoul 4
Trento 4
Vicenza 4
West Jordan 4
Bengaluru 3
Castelfiorentino 3
Chennai 3
Chicago 3
Costabissara 3
Fuzhou 3
Lappeenranta 3
Manchester 3
Mykolayiv 3
Naples 3
Oderzo 3
Oslo 3
Quezon City 3
Richmond 3
Timisoara 3
Zanica 3
Alezio 2
Bari 2
Campi Bisenzio 2
Cesena 2
Cividate Camuno 2
Totale 9.032
Salva come PNG Salva come JPEG
Nome #
Ipertensione arteriosa LINEE GUIDA REGIONE TOSCANA 435
Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy. 330
"Tuscany Registry for sAdden Cardiac DEath": metodo per la creazione di un registro multicentrico per la gestione di eventi di morte improvvisa in età giovanile 326
Optogenetics design of mechanistically-based stimulation patterns for cardiac defibrillation. 281
Atrial Remodeling in Hypertrophic Cardiomyopathy 280
Pathogenesis of hypertrophic cardiomyopathy is mutation rather than disease specific: A comparison of the cardiac troponin T E163R and R92Q mouse models 260
Myocardial Dysfunction in Hypertrophic Cardiomyopathy: Primary Effects of Sarcomeric Mutations Versus Secondary EC-Coupling Remodelling 248
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 238
Regulation of intracellular Na+ in health and disease: pathophysiological mechanisms and implications for treatment 235
Oleuropein aglycone protects against MAO-A-induced autophagy impairment and cardiomyocyte death through activation of TFEB. 217
Late sodium current inhibitors to treat exercise induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium. 208
T-Tubular Electrical Defects Contribute to Blunted β-Adrenergic Response in Heart Failure. 206
Electrical defects of the transverse-axial tubular system in cardiac diseases 204
Quantitative assessment of passive electrical properties of the cardiac T-tubular system by FRAP microscopy 195
A Novel Method of Isolating Myofibrils From Primary Cardiomyocyte Culture Suitable for Myofibril Mechanical Study 186
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center 185
Optical investigation of action potential and calcium handling maturation of hiPSC-cardiomyocytes on biomimetic substrates 177
Altered Ca2+ and Na+ homeostasis in human hypertrophic cardiomyopathy: Implications for arrhythmogenesis 170
Modelling genetic diseases for drug development: Hypertrophic cardiomyopathy 169
Design of muscle contraction assist devices by liquid crystalline elastomers 165
Development of Light-Responsive Liquid Crystalline Elastomers to Assist Cardiac Contraction 164
Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: a Translational Study 157
SODIUM-DEPENDENT GLUCOSE TRANSPORTERS (SGLT) IN HUMAN ISCHEMIC HEART: A NEW POTENTIAL PHARMACOLOGICAL TARGET 149
Selective Blockade of HCN1/HCN2 Channels as a Potential Pharmacological Strategy Against Pain 148
Impact of Mavacamten on Force Generation in Single Myofibrils from Rabbit Psoas and Human Cardiac Muscle 148
Liquid Crystalline Networks toward Regenerative Medicine and Tissue Repair 147
Real-time optical manipulation of cardiac conduction in intact hearts 140
Representativeness of the "Fiesole Misurata" study database for use in pharmaco-epidemiological investigations on adherence to antihypertensive medications 137
Ranolazine prevents phenotype development in a mouse model of hypertrophic cardiomyopathy 135
Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives 132
Advances in Stem Cell Modeling of Dystrophin-Associated Disease: Implications for the Wider World of Dilated Cardiomyopathy 132
The transverse-axial tubular system of cardiomyocytes. 130
UDP-glucose enhances outward K+currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors 129
Late Sodium Current Inhibition Reverses Electro-Mechanical Dysfunction in Human Hypertrophic Cardiomyopathy 128
EFFECTS OF MAVACAMTEN, A FIRST-IN-CLASS INHIBITOR OF SARCOMERIC MYOSINS, ON THE MECHANICS OF ATRIAL AND VENTRICULAR MAMMALIAN MYOCARDIUM AND FAST SKELETAL MUSCLE 127
Arrhythmia susceptibility in a rat model of acute atrial dilation 126
R4496C RyR2 mutation impairs atrial and ventricular contractility 124
Chronic Atrial Fibrillation Alters the Functional Properties of Ifin the Human Atrium 122
Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. 122
Cardiomyocyte-specific Gq signalling and arrhythmias: Novel insights from DREADD technology 120
Action potential propagation in transverse-axial tubular system is impaired in heart failure 116
Functional cardiac imaging by random access microscopy 114
Novel Approach Targeting the Complex Pathophysiology of Hypertrophic Cardiomyopathy: The Impact of Late Sodium Current Inhibition on Exercise Capacity in Subjects with Symptomatic Hypertrophic Cardiomyopathy (LIBERTY-HCM) Trial 109
Reply to entcheva: The impact of T-tubules on action potential propagation in cardiac tissue 109
Time resolved depression of isometric force by Mavacamten in single myofibrils from rabbit psoas and human cardiac muscle 108
Reversible dilated cardiomyopathy: into the thaumaturgy of the heart - Part 2 108
Response to Letter Regarding Article, "Late Sodium Current Inhibition Reverses Electromechanical Dysfunction in Human Hypertrophic Cardiomyopathy" 108
Impact of detubulation on force and kinetics of cardiac muscle contraction 105
Whole heart cytoarchitecture at micron-scale resolution 105
Clinical research in neonates and infants: Challenges and perspectives 105
Design of Biocompatible Liquid Cristal Elastomers Reproducing the Mechanical Properties of Human Cardiac Muscle 105
Isolation and functional characterization of human ventricular cardiomyocytes from fresh surgical samples. 104
Defects in T-tubular electrical activity underlie local alterations of calcium release in heart failure 104
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study 102
Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal 101
Neural Effects on Cardiac Electrophysiology 96
Pharmacological inhibition of serine proteases to reduce cardiac inflammation and fibrosis in atrial fibrillation 96
Impact of RyR2 mutation responsible for Cathecolaminergic Polymorphic Ventricular Tachycardia (CPTV) on the short term interval-force relationship of atrial and ventricular myocardium 95
Targets for therapy in sarcomeric cardiomyopathies. 94
Clinical and Molecular Aspects of Cardiomyopathies: Emerging Therapies and Clinical Trials 93
Histopathological comparison of intramural coronary artery remodeling and myocardial fibrosis in obstructive versus end-stage hypertrophic cardiomyopathy 93
Content of mitochondrial calcium uniporter (MCU) in cardiomyocytes is regulated by microRNA-1 in physiologic and pathologic hypertrophy 93
Impact of R4496C RyR2 mutation on myocardial contractility 90
Letter to the Editor 87
Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy 85
Cellular determinants of arrhythmic rysk in hypertrophic cardiomyopathy 85
Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models 84
[Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018] 83
Structural Mapping of Action Potential Propagation Pathways through Healthy and Diseased Heart 82
Transthyretin aggregates affect viability and functional properties of cardiomyocytes. 80
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives 80
Optical clearing in cardiac imaging: A comparative study 80
Myocardial dysfunction in hypertrophic cardiomyopathy (HCM): primary effects of sarcomeric protein mutations versus secondary E-C coupling remodeling 78
Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018 Abstracts 77
Altered calcium regulation in isolated cardiomyocytes from Egr-1 knock-out mice 77
Mavacamten has a differential impact on force generation in myofibrils from rabbit psoas and human cardiac muscle 77
[Molecular targets and novel pharmacological options to prevent myocardial hypertrophic remodeling] 74
Electrophysiological and molecular remodeling in septal myocytes from fHCM patients 73
1473Microvascular coronary disease and myocardial fibrosis within the spectrum of hypertrophic cardiomyopathy: a histopathologic study 73
T-tubule remodeling in human hypertrophic cardiomyopathy 72
Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations 72
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 71
Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy 71
Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency 68
Novel pharmacological approaches for paediatric hypertrophic cardiomyopathy 67
Transthyretin aggregates affect viability and electrical properties of cardiomyocytes 65
Paradoxical prolongation of QT interval during exercise in patients with hypertrophic cardiomyopathy: cellular mechanisms and implications for diastolic function 57
Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM 57
Mavacamten depresses human atrial contractility in the same EC50% range as human ventricle 56
Optogenetic manipulation of cardiac electrical dynamics using sub-threshold illumination: dissecting the role of cardiac alternans in terminating rapid rhythms 53
Contraction and electrophysiological abnormalities in myofilament mutation-positive and mutation-negative human HCM myocardium 53
Genetic characterization of juvenile sudden cardiac arrest and death in Tuscany: The ToRSADE registry 53
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center 51
Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside 51
Ion Channel Impairment and Myofilament Ca2+ Sensitization: Two Parallel Mechanisms Underlying Arrhythmogenesis in Hypertrophic Cardiomyopathy 50
Novel method of obtaining myofibrils from cardiomyocyte cultures 49
Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development 45
Cardiac safety assessment of a novel recombinant bispecific antibody targeting the ether-à-go-go related gene 1 (hERG1)-β1 integrin macromolecular complex 44
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy 42
Optogenetic confirmation of transverse‐tubular membrane excitability in intact cardiac myocytes 39
Totale 12.246
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.741
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.573 0 0 0 0 243 207 231 251 221 167 206 47
2020/20211.833 127 167 76 198 140 140 113 135 151 403 90 93
2021/2022902 41 49 78 41 50 51 51 46 49 65 149 232
2022/20232.020 178 365 105 126 122 310 236 104 273 30 65 106
2023/2024911 37 92 112 38 55 129 53 186 18 59 51 81
2024/20253.391 241 668 378 817 1.287 0 0 0 0 0 0 0
Totale 12.625